Skip to Content

BAYER 100 mg (Vitrakvi 100 mg)

Generic Name: larotrectinib

Pill with imprint BAYER 100 mg is White, Capsule-shape and has been identified as Vitrakvi 100 mg. It is supplied by Bayer HealthCare Pharmaceuticals Inc..

Vitrakvi is used in the treatment of solid tumors and belongs to the drug class multikinase inhibitors. Vitrakvi 100 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for BAYER 100 mg

Vitrakvi

Generic Name
larotrectinib
Imprint
BAYER 100 mg
Strength
100 mg
Color
White
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Multikinase inhibitors
CSA Schedule
Not a controlled drug
Labeler / Supplier
Bayer HealthCare Pharmaceuticals Inc.
National Drug Code (NDC)
50419-0391

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.